EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Achieve Life Sciences's enterprise value is $89.73 Mil.
Achieve Life Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, Achieve Life Sciences's EV-to-Revenue for today is .
The historical rank and industry rank for Achieve Life Sciences's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Achieve Life Sciences was 2.00. The lowest was -2.03. And the median was 1.51.
ACHV's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.16 * Ranked among companies with meaningful EV-to-Revenue only.
Achieve Life Sciences EV-to-Revenue Historical Data
The historical data trend for Achieve Life Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Achieve Life Sciences's EV-to-Revenue
For the Biotechnology subindustry, Achieve Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achieve Life Sciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Achieve Life Sciences's EV-to-Revenue falls into.
Achieve Life Sciences's current Enterprise Value is $89.73 Mil.
Achieve Life Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences (NAS:ACHV) EV-to-Revenue Explanation
Achieve Life Sciences's share price for today is $3.04.
Achieve Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Achieve Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACHV has been successfully added to your 